Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date of authorisation: 22/11/2018, Revision: 7, Status: Authorised

PSUSA/00001789/202411

Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Apixaban Accord, apixaban, Date of authorisation: 23/07/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagene maraleucel, Date of authorisation: 04/04/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Veklury, remdesivir, Date of authorisation: 03/07/2020, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Kovaltry, octocog alfa, Date of authorisation: 18/02/2016, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Exparel liposomal, bupivacaine, Date of authorisation: 16/11/2020, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Stribild, elvitegravir,cobicistat,emtricitabine,tenofovir disoproxil, Date of authorisation: 24/05/2013, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation: 17/05/2024, Revision: 3, Status: Authorised